SCHEMBL9899283

SCHEMBL9899283

COc1ccc(-c2ncnc3c(C(=O)NC4CCNCC4)c(C)[nH]c23)c(OCC2CC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.42
HTR4 Q13639 2/20 0.40
MELK Q14680 2/20 0.39
ROCK2 O75116 1/20 0.39
GRIN1 Q05586 2/20 0.36
GRIN2B Q13224 2/20 0.36
TDP1 Q9NUW8 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
RIPK2 O43353 1/20 0.34
PAK1 Q13153 1/20 0.34
PRKACA P17612 1/20 0.34
PRKACG P22612 1/20 0.34
PRKACB P22694 1/20 0.34
KDM1A O60341 1/20 0.34
CRHR1 P34998 1/20 0.34
CRHR2 Q13324 1/20 0.34
PTK2 Q05397 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9895930 0.99 HPGDS (0.42) HPGDSHTR4MELKROCK2GRIN1
Hydrochloric Acid SCHEMBL1438768 0.95 HPGDS (0.37) HPGDSHTR4MELKROCK2GRIN1
Hydrochloric Acid SCHEMBL9896783 0.93 HPGDS (0.42) HPGDSHTR4MELKROCK2TDP1
Hydrochloric Acid SCHEMBL27861998 0.93 CHEK1 (0.39) HPGDSHTR4MELKROCK2GRIN1
SCHEMBL9896151 0.93 GRIN1 (0.38) HPGDSMELKROCK2GRIN1GRIN2B
SCHEMBL9897220 0.93 GRIN1 (0.38) HPGDSMELKROCK2GRIN1GRIN2B
SCHEMBL9896147 0.93 GRIN1 (0.38) HPGDSMELKROCK2GRIN1GRIN2B
SCHEMBL9898024 0.92 CYP4F2 (0.39) HPGDSMELKROCK2GRIN1GRIN2B
SCHEMBL9896255 0.92 CYP4F2 (0.39) HPGDSMELKROCK2GRIN1GRIN2B
SCHEMBL9896257 0.92 CYP4F2 (0.39) HPGDSMELKROCK2GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US disclosed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US disclosed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US disclosed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP disclosed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE12, PDE4A HPGDS 1143/4885HTR4 796/4885MELK 4650/4885
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE12, PDE5A, PDE4A HPGDS 982/4885HTR4 1627/4885MELK 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.